During the past decade, Nasz Lekarz Osrodek Badan Klinicznych conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nasz Lekarz Osrodek Badan Klinicznych" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "ACELYRIN Inc." with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nasz Lekarz Osrodek Badan Klinicznych" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Nasz Lekarz Osrodek Badan Klinicznych" are "Crohn Disease" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Psoriatic Arthritis" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Nasz Lekarz Osrodek Badan Klinicznych" in a lesser frequency.

Most popular intervention types in "Nasz Lekarz Osrodek Badan Klinicznych" are "Drug" (19 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrolizumab" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "ABP 654" (1 trials) and "ABY-035" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nasz Lekarz Osrodek Badan Klinicznych" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nasz Lekarz Osrodek Badan Klinicznych". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Nasz Lekarz Osrodek Badan Klinicznych, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Nasz Lekarz Osrodek Badan Klinicznych, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".